VSTM FY 2019 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-34.7% YoY

Gross Profit

$15M83.9% margin

Operating Income

-$132M-758.1% margin

Net Income

-$149M-854.8% margin

EPS (Diluted)

$-27.22

Cash Flow

Operating Cash Flow

-$139M

Free Cash Flow

-$139M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$145M

Total Liabilities

$138M

Stockholders' Equity

$7M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$27M	-34.7%
Gross Profit	$15M	$26M	-43.9%
Operating Income	-$132M	-$95M	-39.6%
Net Income	-$149M	-$72M	-106.0%